Clinical trials
Recruiting Leukemia, Lymphocytic, Chronic, B-Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
121 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 8 |
| 2022 | 15 |
| 2023 | 14 |
| 2024 | 11 |
| 2025 | 29 |
| 2026 | 22 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 121 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 9 |
| BeOne Medicines | 6 |
| Dana-Farber Cancer Institute | 5 |
| Nurix Therapeutics, Inc. | 5 |
| City of Hope Medical Center | 4 |
| Fred Hutchinson Cancer Center | 4 |
| National Cancer Institute (NCI) | 4 |
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| AstraZeneca | 3 |
| Eli Lilly and Company | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 121 |
| Lymphoma, Non-Hodgkin | 30 |
| Lymphoma, Mantle-Cell | 29 |
| Lymphoma, Follicular | 26 |
| Lymphoma, B-Cell, Marginal Zone | 24 |
| Lymphoma, Large B-Cell, Diffuse | 20 |
| Lymphoma | 17 |
| Waldenstrom Macroglobulinemia | 16 |
| Leukemia, Myeloid, Acute | 15 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 15 |
Trials
Showing 1 to 25 of 121. Each trial links to its page on Pharma Observatory.
21 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.